MeSH tree: D12.776.124.486.485.114.224.060
Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard chemotherapy before surgery ...
Jun 2, 2025
0
34
A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment.
Jun 2, 2025
0
26
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had almost four times longer ...
Jun 1, 2025
0
30
New treatment guidance has been developed to help doctors tackle uveitis—one of the leading causes of vision loss. The new clinical guidance, by a team at the University of Bristol, aims to help thousands of sufferers keep ...
May 28, 2025
0
29
Some 10 million people in the U.S. have oral premalignant disease, a group of diseases that show up as red patches, white patches or rough patches in the mouth and that might—or might not—develop into cancer.
May 27, 2025
0
19
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and at a much lower cost than many existing treatments, an initial clinical trial suggests. Further, ...
May 27, 2025
0
50
Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the initial results of D-BIOMARK. ...
May 16, 2025
0
64
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...
May 12, 2025
0
13
A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, demonstrates the potential of human iPS cell-derived respiratory organoids as an effective model for studying ...
Apr 25, 2025
0
12
The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness, according to Yale research published in JAMA Network Open.
Apr 25, 2025
0
47
